全文获取类型
收费全文 | 345261篇 |
免费 | 79404篇 |
国内免费 | 10404篇 |
专业分类
耳鼻咽喉 | 6981篇 |
儿科学 | 10885篇 |
妇产科学 | 3988篇 |
基础医学 | 31979篇 |
口腔科学 | 8462篇 |
临床医学 | 53380篇 |
内科学 | 83518篇 |
皮肤病学 | 15926篇 |
神经病学 | 31000篇 |
特种医学 | 13428篇 |
外国民族医学 | 33篇 |
外科学 | 63824篇 |
综合类 | 26463篇 |
现状与发展 | 98篇 |
一般理论 | 31篇 |
预防医学 | 21839篇 |
眼科学 | 7545篇 |
药学 | 20909篇 |
98篇 | |
中国医学 | 9385篇 |
肿瘤学 | 25297篇 |
出版年
2024年 | 804篇 |
2023年 | 6085篇 |
2022年 | 4372篇 |
2021年 | 9271篇 |
2020年 | 14471篇 |
2019年 | 15714篇 |
2018年 | 18732篇 |
2017年 | 20132篇 |
2016年 | 21716篇 |
2015年 | 23705篇 |
2014年 | 32132篇 |
2013年 | 33246篇 |
2012年 | 19837篇 |
2011年 | 20578篇 |
2010年 | 26510篇 |
2009年 | 25745篇 |
2008年 | 16178篇 |
2007年 | 13509篇 |
2006年 | 15420篇 |
2005年 | 11685篇 |
2004年 | 9288篇 |
2003年 | 8527篇 |
2002年 | 7519篇 |
2001年 | 8396篇 |
2000年 | 6696篇 |
1999年 | 5530篇 |
1998年 | 4830篇 |
1997年 | 4696篇 |
1996年 | 4219篇 |
1995年 | 3944篇 |
1994年 | 2580篇 |
1993年 | 1999篇 |
1992年 | 1849篇 |
1991年 | 1822篇 |
1990年 | 1428篇 |
1989年 | 1475篇 |
1988年 | 1260篇 |
1987年 | 1066篇 |
1986年 | 1058篇 |
1985年 | 869篇 |
1984年 | 634篇 |
1983年 | 579篇 |
1982年 | 562篇 |
1981年 | 449篇 |
1980年 | 392篇 |
1979年 | 359篇 |
1978年 | 368篇 |
1977年 | 411篇 |
1975年 | 296篇 |
1972年 | 315篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的 探讨滋肾育胎丸加减方预防抗磷脂抗体(ACA)阳性者不良妊娠结局的效果及机制研究。方法 选取2016年2月至2019年2月我院收治的89例ACA阳性,先兆性流产或有习惯性流产(RSA)史患者,将采用西医治疗的40例作为对照组,将采用西医联合滋肾育胎丸加减方治疗的49例作为观察组,比较两组中医证候疗效、中医证候积分、ACA-IgA、ACA-IgM、ACA-IgG、凝血指标[血小板聚集功能(PAF)、活化蛋白C(PC)、抗凝血酶(AT)、纤溶酶原激活抑制物-1(PAI-1)]、Th1/Th2细胞因子[干扰素γ(IFN-γ)、白介素-2(IL-2)、白介素-4(IL-4)、白介素-10(IL-10)]、妊娠结局、安全性。结果 治疗2周后检测ACA,观察组2例未降低,对照组11例未降低,观察组未降低患者占比低于对照组(P<0.05);观察组总有效率100.00%高于对照组85.00%(P<0.05);观察组治疗4周、7周后中医证候积分低于对照组(P<0.05);观察组治疗4周、7周后ACA-IgA、ACA-IgM、ACA-IgG低于对照组(P<0.05);观察组治疗4周、7周后PAF、PAI-1低于对照组,PC、AT高于对照组(P<0.05);观察组治疗4周、7周后IFN-γ、IL-2低于对照组,IL-4、IL-10高于对照组(P<0.05);观察组活产率95.92%高于对照组80.00%(P<0.05);组间不良反应总发生率比较,差异无统计学意义(P>0.05)。结论 动态监测ACA对滋肾育胎丸加减方精准应用具有指导意义,指导滋肾育胎丸加减方通过调理脏腑、气血、经络功能,改善先兆性流产或有RSA史患者临床症状及凝血因子指标,降低ACA水平,并可改善患者免疫耐受功能,提高胎儿活产率,且安全性高。 相似文献
22.
23.
Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers 下载免费PDF全文
Thao Phuong Bui Phuong Lan LeLinh Thi Tu Nguyen Le Trung ThoThai Hong Trinh 《Asian Pacific journal of cancer prevention》2022,23(6):1893-1900
Background: Considering the poor prognosis of non-small cell lung cancer (NSCLC), the objective of this study was to examine the potential of plasma-derived vesicles as a source of lung cancer-specific proteins. Extracellular vesicle (EV) cargos are specific to the source cells, hence they have the potential of being a source of cancer-specific proteins. Methods: The proteins differently expressed in cancer were determined and derived from EVs isolated from the plasma of NSCLC patients at the National Lung Hospital. To this end, purification was done using gel filtration chromatography and ultracentrifugation. In addition, nano liquid chromatography mass spectrometry (LC–MS/MS) was used for analyzing. Results: Fifty-seven EV-derived proteins related to NSCLC were highlighted in this research. Some of them have not been addressed before, such as EEF1A1 (elongation factor 1-α1), KPNB1 (Importin subunit beta 1), SRC (proto-oncogene tyrosine-protein kinase) and ACTC1 (actin, alpha cardiac muscle 1). This list was further confirmed through a comparison with ExoCarta and Vesiclepedia. Conclusion: This study is the first work to show the involvement of several novel proteins of small EV (EEF1A1, KPNB1, SRC, and ACTC1) in the progression of NSCLC. The results suggested that they could serve as novel biomarkers for non-small cell lung cancer in the future. 相似文献
24.
25.
26.
Sung‐Hyun Hwang Myung‐Chul Kim Sumin Ji Yeseul Yang Yeji Jeong Yongbaek Kim 《Cancer science》2019,110(4):1256-1267
Metformin, a drug for type 2 diabetes mellitus, has shown therapeutic effects for various cancers. However, it had no beneficial effects on the survival rate of human malignant mesothelioma (HMM) patients. The present study was performed to elucidate the underlying mechanism of metformin resistance in HMM cells. Glucose‐starved HMM cells had enhanced resistance to metformin, demonstrated by decreased apoptosis and autophagy and increased cell survival. These cells showed abnormalities in mitochondria, such as decreased ATP synthesis, morphological elongation, altered mitochondrial permeability transition pore and hyperpolarization of mitochondrial membrane potential (MMP). Intriguingly, Mdr1 was significantly upregulated in mitochondria but not in cell membrane. The upregulated mitochondrial Mdr1 was reversed by treatment with carbonyl cyanide m‐chlorophenyl hydrazone, an MMP depolarization inducer. Furthermore, apoptosis and autophagy were increased in multidrug resistance protein 1 knockout HMM cells cultured under glucose starvation with metformin treatment. The data suggest that mitochondrial Mdr1 plays a critical role in the chemoresistance to metformin in HMM cells, which could be a potential target for improving its therapeutic efficacy. 相似文献
27.
28.
Evelyne Harkemanne Jean‐Louis Dargent Pierre‐Paul Roquet‐Gravy Audrey Bulinckx 《Pediatric dermatology》2019,36(3):365-367
We report a case of benign lymphoplasmacytic plaque (LPP) in a child. These asymptomatic erythematous papulonodular lesions are an emerging clinicopathological entity. Herein, we describe a previously unreported site for LPP lesions, namely, the volar wrist and the distal ipsilateral palm. 相似文献
29.
30.